These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16584873)

  • 21. Chronic obstructive pulmonary disease and asthma.
    Hall M
    Home Healthc Nurse; 2012; 30(10):603-12; quiz 612-4. PubMed ID: 23131690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can corticosteroids be beaten in future asthma therapy?
    Amon A; Pahl A; Szelenyi I
    Pharmazie; 2006 Feb; 61(2):122-4. PubMed ID: 16526559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme.
    Sel S; Wegmann M; Dicke T; Sel S; Henke W; Yildirim AO; Renz H; Garn H
    J Allergy Clin Immunol; 2008 Apr; 121(4):910-916.e5. PubMed ID: 18325571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma.
    Ram A; Mabalirajan U; Singh SK; Singh VP; Ghosh B
    Int Immunopharmacol; 2008 Jun; 8(6):893-9. PubMed ID: 18442795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycyrrhizin alleviates experimental allergic asthma in mice.
    Ram A; Mabalirajan U; Das M; Bhattacharya I; Dinda AK; Gangal SV; Ghosh B
    Int Immunopharmacol; 2006 Sep; 6(9):1468-77. PubMed ID: 16846841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
    Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
    Olmez D; Babayigit A; Uzuner N; Erbil G; Karaman O; Yilmaz O; Cetin EO; Ozogul C
    Exp Lung Res; 2008 Oct; 34(8):501-11. PubMed ID: 18850376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New developments in lung function measurements in rodents.
    Hoymann HG
    Exp Toxicol Pathol; 2006 Jun; 57 Suppl 2():5-11. PubMed ID: 16618537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with chitin microparticles is protective against lung histopathology in a murine asthma model.
    Ozdemir C; Yazi D; Aydogan M; Akkoc T; Bahceciler NN; Strong P; Barlan IB
    Clin Exp Allergy; 2006 Jul; 36(7):960-8. PubMed ID: 16839412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of asthma: reprise or reboot?
    Mullane K; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):131-9. PubMed ID: 23831953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asthma therapy and airway remodeling.
    Mauad T; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 2007 Nov; 120(5):997-1009; quiz 1010-1. PubMed ID: 17681364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostanoids as pharmacological targets in COPD and asthma.
    Rolin S; Masereel B; Dogné JM
    Eur J Pharmacol; 2006 Mar; 533(1-3):89-100. PubMed ID: 16458293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dispensed volumes of anti-asthmatic drugs related to the prevalence of asthma and COPD in Sweden.
    Haupt D; Wettermark B; Nilsson JL
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):461-7. PubMed ID: 18302301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication?
    Sadowska AM; Klebe B; Germonpré P; De Backer WA
    Steroids; 2007 Jan; 72(1):1-6. PubMed ID: 17145070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovalbumin-sensitized mice are good models for airway hyperresponsiveness but not acute physiological responses to allergen inhalation.
    Zosky GR; Larcombe AN; White OJ; Burchell JT; Janosi TZ; Hantos Z; Holt PG; Sly PD; Turner DJ
    Clin Exp Allergy; 2008 May; 38(5):829-38. PubMed ID: 18070158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small airways: an important but neglected target in the treatment of obstructive airway diseases.
    Sturton G; Persson C; Barnes PJ
    Trends Pharmacol Sci; 2008 Jul; 29(7):340-5. PubMed ID: 18514920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing the phenotype in novel acute and chronic murine models of allergic asthma.
    Fernandez-Rodriguez S; Ford WR; Broadley KJ; Kidd EJ
    Int Immunopharmacol; 2008 May; 8(5):756-63. PubMed ID: 18387519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods used in clinical development of novel anti-asthma therapies.
    Diamant Z; Boot D; Kamerling I; Bjermer L
    Respir Med; 2008 Mar; 102(3):332-8. PubMed ID: 18061420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
    Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
    Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.